A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
Public ClinicalTrials.gov record NCT03151304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-Stage, Open-Label Phase 2 Study of Pracinostat and Azacitidine in Patients With IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated With Hypomethylating Agents
Study identification
- NCT ID
- NCT03151304
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Helsinn Healthcare SA
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Azacitidine Drug
- Pracinostat Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2017
- Primary completion
- Nov 30, 2020
- Completion
- Nov 30, 2020
- Last update posted
- Mar 1, 2022
2017 – 2020
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | — |
| Scripps Cancer Center-Mercy | San Diego | California | 92103 | — |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | — |
| georgia cancer Center | Augusta | Georgia | 30912 | — |
| Pontchartrain cancer Center | Covington | Louisiana | 70433 | — |
| RCCA MD LLC (The Center for Cancer and Blood Disorders) | Bethesda | Maryland | 20817 | — |
| Michigan Center of Medical Research | Farmington Hills | Michigan | 48334 | — |
| Michigan State University, Breslin Cancer Center | Lansing | Michigan | 48910 | — |
| university of minnesota medical Center, Fairview | Minneapolis | Minnesota | 55455 | — |
| Mercy Medical Research Institute | Springfield | Missouri | 65807 | — |
| New Mexico Cancer care Alliance | Albuquerque | New Mexico | 87131 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27534 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Cancer Centers of Southwest Oklahoma | Lawton | Oklahoma | 73501 | — |
| Oklahoma Cancer Specialists and Research Institute | Tulsa | Oklahoma | 74146 | — |
| Providence Portland Medical center | Portland | Oregon | 97213 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| UVA Health System Division of Hematology & Oncology | Charlottesville | Virginia | 22908 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Universityof Wisconsin Clinical Science Center | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03151304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2022 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03151304 live on ClinicalTrials.gov.